Nephrotic Syndrome 2022

CME

Advertisement

This half-day course addresses nephrotic syndrome, minimal change disease (MCD) and focal segmental glomerulosclerosis (FSGS) and is a comprehensive update in diagnosis & treatment of primary podocytopathies and membranous nephropathy (antibodies against the M-type phospholipase A2 receptor (PLA2RAb) and newer antigens; risk stratification and treatment paradigms). 5 AMA PRA Category 1 Credits™ - maximum

5 ABIM MOC points

Date

October 21, 2022

Location

Virtual Conference

Email

cme@columbia.edu

Website

www.eventleaf.com/Attendee/Attendee/EventPage?eId=ckm2mgr9Q5NfAcDv9sokVQ%3D%3D/

Advertisement